Related Experiment Video
Updated: Apr 12, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
Buprenorphine treatment for narcotic addiction: not without risks
Randy A Sansone1, Lori A Sansone1
1R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, OH, and Director of Psychiatry Education at Kettering Medical Center in Kettering, OH. L. Sansone is a civilian family medicine physician at the Primary Care Clinic at Wright-Patterson Air Force Base in Dayton, OH. The views and opinions expressed in this article are those of the authors and do not reflect the official policy or position of the United States Air Force, Department of Defense, or United States Government.
Medication-assisted treatment using buprenorphine and buprenorphine/naloxone offers benefits for opioid addiction but carries risks. Clinicians must monitor the fluctuating risk-benefit balance of these medications.
Area of Science:
- Pharmacology
- Addiction Medicine
- Public Health
Background:
- Medication-assisted treatment (MAT) has shown success in managing narcotic addiction.
- Buprenorphine and buprenorphine/naloxone are key pharmacological agents in MAT.
- Understanding the risks associated with these medications is crucial for clinicians.
Purpose of the Study:
- To review the relevant risks associated with buprenorphine and buprenorphine/naloxone in treating narcotic addiction.
- To emphasize the importance of monitoring the risk-benefit profile of these treatments.
Main Methods:
- Literature review of pharmacological approaches to narcotic addiction treatment.
- Analysis of risks including diversion, misuse, infectious complications, and overdose.
- Examination of factors heightening overdose risk, such as coadministration with other substances.
Main Results:
- Buprenorphine and buprenorphine/naloxone can be diverted and misused, particularly through injection or nasal administration.
- Illicit injection of these substances carries risks of infectious complications and fatal overdose.
- The risk of fatal overdose is increased when buprenorphine is combined with benzodiazepines or sedative/hypnotics.
Conclusions:
- While MAT with buprenorphine offers significant benefits for opioid addiction, inherent risks necessitate careful management.
- Continuous monitoring of the risk-benefit ratio is essential for safe and effective clinical practice.
- Familiarity with potential adverse events and misuse patterns is vital for all healthcare providers.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Pharmaceutical Poisoning: Treatment Strategies
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Drug Abuse and Addiction: Pharmacological Phenomena

